<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2413-4341</journal-id>
<journal-title><![CDATA[Revista Paraguaya de Reumatología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. parag. reumatol.]]></abbrev-journal-title>
<issn>2413-4341</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Paraguaya de Reumatología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2413-43412023000100004</article-id>
<article-id pub-id-type="doi">10.18004/rpr/2023.09.01.4</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Caracterización y mortalidad de pacientes con enfermedades Reumatológica ingresados en una unidad de cuidados intensivos adultos del Paraguay]]></article-title>
<article-title xml:lang="en"><![CDATA[Characteristics and mortality of patients with rheumatologic diseases admitted at an intensive care unit of Paraguay]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Figueredo]]></surname>
<given-names><![CDATA[Jessica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Colmán]]></surname>
<given-names><![CDATA[Iris]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fretes]]></surname>
<given-names><![CDATA[Federico]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pederzani]]></surname>
<given-names><![CDATA[Marcelo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fontclara]]></surname>
<given-names><![CDATA[Lorena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Caballero]]></surname>
<given-names><![CDATA[Ricardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Añazco]]></surname>
<given-names><![CDATA[Patricia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bianco]]></surname>
<given-names><![CDATA[Hugo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Figueredo]]></surname>
<given-names><![CDATA[Belinda]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Asunción Facultad de Ciencias Médicas Hospital de Clínicas, Departamento de Cuidados Intensivos Adultos]]></institution>
<addr-line><![CDATA[San Lorenzo ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2023</year>
</pub-date>
<volume>9</volume>
<numero>1</numero>
<fpage>4</fpage>
<lpage>9</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2413-43412023000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2413-43412023000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2413-43412023000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: Las enfermedades reumatológicas no son infrecuentes en la población general. Este grupo de pacientes suele requerir hospitalización por diversas causas y hasta un tercio puede ingresar a la Unidad de Cuidados Intensivos (UCI). El pronóstico puede ser desfavorable, sobretodo en presencia de compromiso renal. Objetivo: Caracterizar a los pacientes reumatológicos ingresados a Cuidados Intensivos y determinar la mortalidad. Métodos: Se realizó un estudio descriptivo, retrospectivo de corte transversal. Los datos fueron obtenidos de las historias clínicas de los pacientes con enfermedades reumatológicas ingresados al Departamento de Cuidados Intensivos Adultos del Hospital de Clínicas desde enero de 2021 hasta diciembre de 2022. Resultados: Veintinueve pacientes con enfermedades reumatológicas ingresaron en los dos años de estudio. Con una mediana de edad de 37 años (RIC 22,5), veintitrés fueron mujeres (79,31%). Tenían lupus eritematoso sistémico veinte pacientes (68,9%); cinco con artritis reumatoide (17,2%) y los cuatros pacientes restantes tenían enfermedad mixta del tejido conectivo, Síndrome de Sjogren, Síndrome de Superposición y Vasculitis de Churg Strauss (3,44%). Las comorbilidades más frecuentes fueron: hipertensión arterial (55%) y nefropatía (41,3%). Las causas de ingreso a la UCI fueron médicas (62%) y quirúrgicas (38%). Entre las médicas, la insuficiencia respiratoria aguda fue el principal motivo (44%), seguido por shock (27%) e infecciones sobre agregadas (11,1%). La puntuación media de APACHE II (Age and Chronic Health Evaluation) fue 17 ± 10; SOFA al ingreso (Sequential Organ Failure Assessment): 6 ± 8,5 y en los pacientes lúpicos la Escala de SLEDAI (Systemic Lupus Erythematosus Disease Activity Measure): 10,6 ± 8,3. Recibieron asistencia respiratoria mecánica (ARM) 19 pacientes (65,5%) con una mediana de días de ARM de 6 (RIC 9). Utilizaron drogas vasoactivas 65,5% y hemodiálisis 17,2%. Se administró metil- prednisolona a 10 de los pacientes (37,9%), además 4 de ellos requirieron ciclofosfamida y 3 inmunoglobulinas. Durante su hospitalización desarrollaron falla renal aguda 13 (44,8%) y sobreinfecciones12 pacientes (41,3%), de los cuales en 6 se aislaron Gram positivos en sangre. La mediana de estancia fue de 6 días (RIC:10) y la mortalidad en UCI fue del 37,9% (11 pacientes). Conclusiones: En nuestro estudio la población fue principalmente de mujeres jóvenes con comorbilidades, que ingresaron graves a terapia intensiva, la mayoría por causas médicas. Dos tercios requirieron ARM y drogas vasoactivas. Presentaron complicaciones como la falla renal aguda y sobreinfecciones bacterianas. La mortalidad fue del 38%, solo un poco mayor que la correspondiente al escore de gravedad del ingreso.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: Rheumatologic diseases are not unusual in general population. This group of patients usually requires hospitalization for various causes and up to a third of them may be admitted to the Intensive Care Unit (ICU). The prognosis can be unfavorable, especially in the presence of renal involvement. Objective: To characterize rheumatologic patients admitted to Intensive Care and determi- ne their mortality. Methods: We conducted a descriptive, retrospective cross-sectional study. Data were collec- ted from medical records of patients with rheumatic diseases admitted to the ICU of the Hospital de Clínicas from January 2021 to December 2022. Results: Twenty-nine patients with rheumatic diseases were admitted in the two years of the study. Twenty-three (79.31%) were women. The median age was 37 years (IQR 22.5). Twenty patients (68.9%) had Systemic Lupus Erythematosus, five (17.2%) rheumatoid arthri- tis and there maining four patients (3.44%) had mixed connective tissue disease, Sjogren&#8216;s Syndrome, Overlap Syndrome and Churg Strauss Vasculitis. The most frequent comorbidi- ties were: arterial hypertension (55%) and nephropathy (41.3%). The causes of admission to the ICU were medical (62%) and surgical (38%). Between medical causes, respiratory failure was the main reason (44%), followed by shock (27%) and intercurrent infections (11.1%). The mean APACHE II (Assessment of Age and Chronic Health) score was 17 ± 10; SOFA on admission (Sequential Organ Failure Assessment): 6 ± 8.5 and the SLEDAI Scale (Systemic Lupus Erythematosus Disease Activity Measure) in lupus patients: 10.6 ± 8.3. Nineteen patients (65.5%) received mechanical ventilation (MV) with a median number of days on MV of 6 (IQR 9). Vasoactive drugs were used by 65.5% and hemodialysis by 17.2%. Methylprednisolone was administered to 10 of the patients (37.9%), in addition 4 of them required cyclophosphamide and 3 immunoglobulins. During hospitalization thirteen patients (44.8%) developed acute renal failure and twelve of them (41.3%) intercurrent in- fections; 6 of them with blood stream Gram Positive isolation. The median length of stay in the ICU was 6 days (IQR: 10) and mortality was 37.9% (eleven patients). Conclusions: In our study, the population was mainly young women with several comorbidities, who were admitted in serious condition to the ICU, most of them for medical reasons. Two-thirds required MV and vasoactive drugs. They presented complications such as acute renal failure and intercurrent infections. Mortality was 38%, only a little higher than that corresponding to the gravity score of income.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Terapia intensiva]]></kwd>
<kwd lng="es"><![CDATA[Lupus]]></kwd>
<kwd lng="en"><![CDATA[Intensive therapy]]></kwd>
<kwd lng="en"><![CDATA[Lupus]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ranzani]]></surname>
<given-names><![CDATA[OT]]></given-names>
</name>
<name>
<surname><![CDATA[Battaini]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Moraes]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Prada]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Pinaffi]]></surname>
<given-names><![CDATA[JV]]></given-names>
</name>
<name>
<surname><![CDATA[Giannini]]></surname>
<given-names><![CDATA[FP]]></given-names>
</name>
<name>
<surname><![CDATA[Shinjo]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Azevedo]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcomes and organ dysfunctions of critically ill patients with systemic lupus erythemato- sus and other systemic rheumatic diseases]]></article-title>
<source><![CDATA[Braz J Med Biol Res]]></source>
<year>2011</year>
<volume>44</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1184-93</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arjmand]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Shahriarirad]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Shenavandeh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Fallahi]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Determination of the main causes, outcome, and prognostic factors of patients with rheumatologic diseases admitted to the medical intensive care unit in Southern Iran]]></article-title>
<source><![CDATA[Clin Rheumatol]]></source>
<year>2022</year>
<volume>41</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>3859-68</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Camargo]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Tobón]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Fonseca]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Uribe]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature]]></article-title>
<source><![CDATA[Lupus]]></source>
<year>2005</year>
<volume>14</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>315-20</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aragón]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Ordoñez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Quintana]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Suárez-Avellaneda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gallego]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Gallego]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical characterization, outcomes, and prognosis in patients with systemic lupus erythematosus admitted to the intensive care unit]]></article-title>
<source><![CDATA[Lupus]]></source>
<year>2020</year>
<volume>29</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1133-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brünnler]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Susewind]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffmann]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Rockmann]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ehrenstein]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Fleck]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcomes and Prognostic Factors in Patients with Rheu- matologic Diseases Admitted to the ICU]]></article-title>
<source><![CDATA[Intern Med]]></source>
<year>2015</year>
<volume>54</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>1981-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fontclara]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bianco]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo de mortalidad en pacientes con lupus eritematoso sistémico en una unidad de cuidados intensivos]]></article-title>
<source><![CDATA[Rev. Parag. Reumatol]]></source>
<year>2015</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>85-93</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrizosa]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Aponte]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cartagena]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Cervera]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ospina]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores asociados a la mortalidad en pacientes con enfermedades autoinmunes ingresados en la unidad de cuidados intensivos de Bogotá, Colombia]]></article-title>
<source><![CDATA[Front. Inmunol]]></source>
<year>2017</year>
<volume>8</volume>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Du]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Qin]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[XY]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Rheumatol]]></source>
<year>2020</year>
<volume>39</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>3479-88</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dumas G]]></surname>
<given-names><![CDATA[Géri G]]></given-names>
</name>
<name>
<surname><![CDATA[Montlahuc C]]></surname>
<given-names><![CDATA[Chemam S]]></given-names>
</name>
<name>
<surname><![CDATA[Dangers L]]></surname>
<given-names><![CDATA[Pichereau]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2015</year>
<volume>148</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>927-35</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Richter]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Listing]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Klopsch]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kapelle]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kaufmann]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumato id arthritis]]></article-title>
<source><![CDATA[Ann Rheum Dis]]></source>
<year>2016</year>
<volume>75</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1667-73</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fujiwara]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tokuda]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Momii]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Shiomoto]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Tsushima]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Akasaki]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic factors for the short-term mortality of patients with rheumatoid arthritis admitted to intensive care units]]></article-title>
<source><![CDATA[BMC Rheumatol]]></source>
<year>2020</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>64</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Janssen]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Karnad]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Guntupalli]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome]]></article-title>
<source><![CDATA[Crit Care Clin]]></source>
<year>2002</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>729-48</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beil]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sviri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[de la Guardia]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Stav]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ben-Chetrit]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[van Heerden]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognosis of patients with rheumatic diseases admitted to intensive care]]></article-title>
<source><![CDATA[Anaesth Intensive Care]]></source>
<year>2017</year>
<volume>45</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>67-72</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avouac]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Amrouche]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Meune]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rey]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kahan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Allanore]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years]]></article-title>
<source><![CDATA[Semin Arthritis Rheum]]></source>
<year>2017</year>
<volume>46</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>537-43</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Larcher]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Pineton de Chambrun]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Garnier]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rubenstein]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Carr]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Charbit]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[One-Year Outcome of Critically Ill Patients With Systemic Rheumatic Disease: A Multicenter Cohort Study]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2020</year>
<volume>158</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1017-26</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Antón]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Marcos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gandía]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Merchán]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study]]></article-title>
<source><![CDATA[Clin Exp Rheumatol]]></source>
<year>2012</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>338-44</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faguer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ciroldi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mariotte]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Galicier]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rybojad]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Canet]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill patients with systemic rheumatic diseases]]></article-title>
<source><![CDATA[Eur JIntern Med]]></source>
<year>2013</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e40-4</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrett]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Abramovich]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Dreiher]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Novack]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Abu-Shakra]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Short- and long-term mortality due to sepsis in patients with rheumatoid arthritis]]></article-title>
<source><![CDATA[Rheumatol Int]]></source>
<year>2017</year>
<volume>37</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1021-6</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chabert]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Danjou]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Mezidi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Berthiller]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bestion]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fred]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Short- and long-term prognosis of acute critically ill patients with systemic rheumatic diseases: A retrospective multicentre study]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>2021</year>
<volume>100</volume>
<numero>35</numero>
<issue>35</issue>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Yim]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Yoo]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[YW]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcome of patients with connective tissue disease requiring intensive care for respiratory failure]]></article-title>
<source><![CDATA[Rheumatol Int]]></source>
<year>2012</year>
<volume>32</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>3353-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Godeau]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mortier]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Roy]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Chevret]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bouachour]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Schlemmer]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients]]></article-title>
<source><![CDATA[J Rheumatol]]></source>
<year>1997</year>
<volume>24</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1317-23</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mustafa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gladston Chelliah]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know]]></article-title>
<source><![CDATA[Rheumatol Int]]></source>
<year>2018</year>
<volume>38</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1163-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Keyßer]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiologie und Outcome von Rheumapatienten auf der Intensivstation]]></article-title>
<source><![CDATA[Z Rheumatol]]></source>
<year>2019</year>
<volume>78</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>925-31</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
